CANYON CAPITAL ADVISORS LLC 13D and 13G filings for Acorda Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:52 pm Sale | 2022-12-31 | 13G | Acorda Therapeutics, Inc. ACOR | CANYON CAPITAL ADVISORS LLC | 0 0.000% | -32,452 (Position Closed) | Filing |
| 2022-02-14 4:56 pm Purchase | 2021-12-31 | 13G | Acorda Therapeutics, Inc. ACOR | CANYON CAPITAL ADVISORS LLC | 32,452 5.790% | 22,633 (+230.52%) | Filing |
| 2021-04-28 6:13 pm Sale | 2020-12-31 | 13G | Acorda Therapeutics, Inc. ACOR | CANYON CAPITAL ADVISORS LLC | 9,818 1.820% | -65,179 (-86.91%) | Filing |
| 2021-02-16 4:16 pm Purchase | 2020-12-31 | 13G | Acorda Therapeutics, Inc. ACOR | CANYON CAPITAL ADVISORS LLC | 74,997 13.910% | 74,997 (New Position) | Filing |